Latest It Compliance News

Intelligent Monitoring Group (IMG) is set to acquire Bluesky Holdco, owner of Tyco New Zealand and Red Wolf Security, in a deal expected to boost FY26 EBITDA by 28.3%. This move significantly strengthens IMG’s commercial security and fire services presence across Australasia.

Rand Mining has released a replacement exploration report for the East Kundana Joint Venture, highlighting new JORC disclosures and promising high-grade gold assay results from the Ambition prospect.

Tribune Resources has replaced its initial FY2026 Q1 EKJV exploration report with a more detailed version, revealing promising high-grade gold assay results and enhanced compliance disclosures.

Ryzon Materials has lodged a second supplementary prospectus extending its capital raising offer and clarifying key debt-for-equity transactions with Yantai, updating its financial outlook ahead of ASX reinstatement.

St Barbara Limited’s latest Feasibility Study confirms the Simberi Expansion Project as a long-life, low-cost gold and silver operation with robust economics and a 13-year mine life. The project promises over 2 million ounces of gold production and competitive costs, pending key regulatory approvals.

Tissue Repair Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

Anax Metals has completed a $2.4 million strategic placement by issuing over 219 million shares to Gold Valley Pilbara, strengthening its capital base. The placement was executed under existing capacity and accompanied by a cleansing notice confirming regulatory compliance.

Charger Metals NL has retained 100% ownership of its Lake Johnston Lithium and Gold Project after Rio Tinto Exploration withdrew from their farm-in agreement. The company plans an expanded drilling campaign in early 2026 to grow its maiden lithium resource.

Vulcan Steel Limited has explained the late filing of a director’s interest notice due to an administrative error and outlined steps to strengthen compliance. The company commits to enhanced reminders and board training to prevent future delays.

Mayne Pharma has rejected Cosette Pharmaceuticals’ notice to terminate their merger agreement, citing Cosette’s failure to meet obligations that led to regulatory approval issues. The dispute raises fresh uncertainty over the proposed acquisition’s future.

Orion Minerals has responded to an ASX price query following a recent uptick in its share price, confirming no undisclosed material information exists while highlighting ongoing financing talks with Glencore.

Immuron Limited reports topline results from a Uniformed Services University trial of a third-party ETEC product that missed its primary endpoint, reaffirming commitment to its established Travelan dosing ahead of FDA discussions.